Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(16):1211-1218; doi:10.1093/jnci/djg011
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (89)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wu, X.
Right arrow Articles by Spitz, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, X.
Right arrow Articles by Spitz, M. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

ARTICLE

Telomere Dysfunction: A Potential Cancer Predisposition Factor

Xifeng Wu, Christopher I. Amos, Yong Zhu, Hua Zhao, Barton H. Grossman, Jerry W. Shay, Sherry Luo, Waun Ki Hong, Margaret R. Spitz

Affiliations of authors: X. Wu, C. I. Amos, Y. Zhu, H. Zhao, S. Luo, M. R. Spitz (Department of Epidemiology), B. H. Grossman (Department of Urology), W. K. Hong (Department of Thoracic/Head and Neck Medical Oncology), The University of Texas M. D. Anderson Cancer Center, Houston; J. W. Shay, Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, TX.

Correspondence to: Xifeng Wu, MD, PhD, Department of Epidemiology, Box 189, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 (e-mail: xwu{at}mdanderson.org).

Background: Genetic instability associated with telomere dysfunction (i.e., short telomeres) is an early event in tumorigenesis. We investigated the association between telomere length and cancer risk in four ongoing case–control studies. Methods: All studies had equal numbers of case patients and matched control subjects (92 for head and neck cancer, 135 for bladder cancer, 54 for lung cancer, and 32 for renal cell carcinoma). Telomere length was measured in peripheral blood lymphocytes from study participants. Genetic instability was assessed with the comet assay. Patient and disease characteristics were collected and analyzed for associations with risk for these cancers. All statistical tests were two-sided. Results: Telomeres were statistically significantly shorter in patients with head and neck cancer (6.5 kilobases [kb]) than in control subjects (7.4 kb) (difference = 0.9 kb, 95% confidence interval [CI] = 0.5 to 1.2 kb; P<.001). Nine percent of patients with head and neck cancer were in the longest quartile of telomere length, whereas 59% were in the shortest quartile. Similar patterns were observed for lung, renal cell, and bladder cancer. When subjects were categorized into telomere length quartiles defined by the distribution in control subjects, the following inverse relationship between telomere length and cancer risk was observed: adjusted odds ratios [ORs] for decreasing quartiles = 0.84 (95% CI = 0.36 to 1.97), 1.77 (95% CI = 0.72 to 4.36), and 5.11 (95% CI = 1.90 to 13.77). In stratified analysis, we found a suggestive greater-than-additive interaction between smoking status and telomere length: for ever smokers with short telomeres, OR = 25.05 (95% CI = 6.91 to 90.73); for never smokers with short telomeres, OR = 6.18 (95% CI = 1.72 to 22.13); and for ever smokers with long telomeres, OR = 6.49 (95% CI = 1.54 to 27.38). Telomere length was statistically significantly and inversely associated with baseline and mutagen-induced genetic instability. Conclusion: Short telomeres appear to be associated with increased risks for human bladder, head and neck, lung, and renal cell cancers.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Hou, S. A. Savage, M. J. Blaser, G. Perez-Perez, M. Hoxha, L. Dioni, V. Pegoraro, L. M. Dong, W. Zatonski, J. Lissowska, et al.
Telomere Length in Peripheral Leukocyte DNA and Gastric Cancer Risk
Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3103 - 3109.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. E. Choi, H.-G. Kang, J. S. Jang, Y. Y. Choi, M. J. Kim, J. S. Kim, H.-S. Jeon, W. K. Lee, S. I. Cha, C. H. Kim, et al.
Polymorphisms in Telomere Maintenance Genes and Risk of Lung Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2773 - 2781.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. Paul, M. Cattaneo, A. D'Angelo, F. Sampietro, I. Fermo, C. Razzari, G. Fontana, N. Eugene, P. F. Jacques, and J. Selhub
Telomere Length in Peripheral Blood Mononuclear Cells Is Associated with Folate Status in Men
J. Nutr., July 1, 2009; 139(7): 1273 - 1278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Q. Xu, C. G Parks, L. A DeRoo, R. M Cawthon, D. P Sandler, and H. Chen
Multivitamin use and telomere length in women
Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1857 - 1863.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
J. Xing, J. A. Ajani, M. Chen, J. Izzo, J. Lin, Z. Chen, J. Gu, and X. Wu
Constitutive Short Telomere Length of Chromosome 17p and 12q but not 11q and 2p Is Associated with an Increased Risk for Esophageal Cancer
Cancer Prevention Research, May 1, 2009; 2(5): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. De Vivo, J. Prescott, J. Y.Y. Wong, P. Kraft, S. E. Hankinson, and D. J. Hunter
A Prospective Study of Relative Telomere Length and Postmenopausal Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1152 - 1156.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Svenson, B. Ljungberg, and G. Roos
Telomere Length in Peripheral Blood Predicts Survival in Clear Cell Renal Cell Carcinoma
Cancer Res., April 1, 2009; 69(7): 2896 - 2901.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Kim, C. G. Parks, L. A. DeRoo, H. Chen, J. A. Taylor, R. M. Cawthon, and D. P. Sandler
Obesity and Weight Gain in Adulthood and Telomere Length
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 816 - 820.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. T. Calado, J. A. Regal, M. Hills, W. T. Yewdell, L. F. Dalmazzo, M. A. Zago, P. M. Lansdorp, D. Hogge, S. J. Chanock, E. H. Estey, et al.
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
PNAS, January 27, 2009; 106(4): 1187 - 1192.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Nilbert, S. Timshel, I. Bernstein, and K. Larsen
Role for Genetic Anticipation in Lynch Syndrome
J. Clin. Oncol., January 20, 2009; 27(3): 360 - 364.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. Mayor
Unravelling the secrets of ageing
BMJ, January 8, 2009; 338(jan08_3): a3024 - a3024.
[Full Text]


Home page
Ann OncolHome page
S. H. Ghaffari, N. Shayan-Asl, A. H. Jamialahmadi, K. Alimoghaddam, and A. Ghavamzadeh
Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival
Ann. Onc., November 1, 2008; 19(11): 1927 - 1934.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
Hu Jian, Sun Li, Zhang Chong, and X.-L. Zhou
Expression of Telomeric Repeat Binding Factor 1 Protein in Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive
International Journal of Surgical Pathology, October 1, 2008; 16(4): 414 - 418.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Capezzone, S. Cantara, S. Marchisotta, S. Filetti, M. M. De Santi, B. Rossi, G. Ronga, C. Durante, and F. Pacini
Short Telomeres, Telomerase Reverse Transcriptase Gene Amplification, and Increased Telomerase Activity in the Blood of Familial Papillary Thyroid Cancer Patients
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3950 - 3957.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Svenson, K. Nordfjall, B. Stegmayr, J. Manjer, P. Nilsson, B. Tavelin, R. Henriksson, P. Lenner, and G. Roos
Breast Cancer Survival Is Associated with Telomere Length in Peripheral Blood Cells
Cancer Res., May 15, 2008; 68(10): 3618 - 3623.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. A. Risques, T. L. Vaughan, X. Li, R. D. Odze, P. L. Blount, K. Ayub, J. L. Gallaher, B. J. Reid, and P. S. Rabinovitch
Leukocyte Telomere Length Predicts Cancer Risk in Barrett's Esophagus
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2649 - 2655.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Shen, M. B. Terry, I. Gurvich, Y. Liao, R. T. Senie, and R. M. Santella
Short Telomere Length and Breast Cancer Risk: A Study in Sister Sets
Cancer Res., June 1, 2007; 67(11): 5538 - 5544.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. McGrath, J. Y.Y. Wong, D. Michaud, D. J. Hunter, and I. De Vivo
Telomere Length, Cigarette Smoking, and Bladder Cancer Risk in Men and Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 815 - 819.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. P. Gardner, M. Kimura, W. Chai, J. F. Durrani, L. Tchakmakjian, X. Cao, X. Lu, G. Li, A. P. Peppas, J. Skurnick, et al.
Telomere Dynamics in Macaques and Humans
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 367 - 374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Xing, Y. Zhu, H. Zhao, H. Yang, M. Chen, M. R. Spitz, and X. Wu
Differential Induction in Telomerase Activity among Bladder Cancer Patients and Controls on {gamma}-Radiation
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 606 - 609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
U. Tabori, S. Nanda, H. Druker, J. Lees, and D. Malkin
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
Cancer Res., February 15, 2007; 67(4): 1415 - 1418.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
P. Thomas and M. Fenech
A review of genome mutation and Alzheimer's disease
Mutagenesis, January 1, 2007; 22(1): 15 - 33.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. M. Unryn, D. Hao, S. Gluck, and K. T. Riabowol
Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer.
Clin. Cancer Res., November 1, 2006; 12(21): 6345 - 6350.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. O'Sullivan, R. A. Risques, M. T. Mandelson, L. Chen, T. A. Brentnall, M. P. Bronner, M. P. MacMillan, Z. Feng, J. R. Siebert, J. D. Potter, et al.
Telomere length in the colon declines with age: a relation to colorectal cancer?
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Gu, M. R. Spitz, H. Zhao, J. Lin, H.B. Grossman, C. P. Dinney, and X. Wu
Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study
Carcinogenesis, October 1, 2005; 26(10): 1741 - 1747.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Broberg, J. Bjork, K. Paulsson, M. Hoglund, and M. Albin
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer
Carcinogenesis, July 1, 2005; 26(7): 1263 - 1271.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. W. Shay and W. E. Wright
Senescence and immortalization: role of telomeres and telomerase
Carcinogenesis, May 1, 2005; 26(5): 867 - 874.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.